These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22123025)

  • 1. Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study.
    Hovstadius B; Petersson G
    BMC Health Serv Res; 2011 Nov; 11():326. PubMed ID: 22123025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition cost of dispensed drugs in individuals with multiple medications--a register-based study in Sweden.
    Hovstadius B; Åstrand B; Persson U; Petersson G
    Health Policy; 2011 Jul; 101(2):153-61. PubMed ID: 21514685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence, therapeutic intensity, and the number of dispensed drugs.
    Hovstadius B; Petersson G
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1255-61. PubMed ID: 21913278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
    Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
    Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
    Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessing the Effects of Prescription Adjustment and Medication Non-adherence Associated with Medication Efficacy Classifications from Leftover Drugs through the SETSUYAKU-BAG Campaign].
    Kobayashi D; Koyanagi K; Kubota T; Sakamoto Y; Kihara T; Miisho T; Kasaki T; Kunitake M; Takeshita F; Ando E; Baba T; Seo T; Tanaka T; Shimazoe T
    Yakugaku Zasshi; 2018; 138(10):1313-1322. PubMed ID: 30270277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy in Sweden: health care costs and loss of productivity--a register-based approach.
    Bolin K; Lundgren A; Berggren F; Källén K
    Eur J Health Econ; 2012 Dec; 13(6):819-26. PubMed ID: 22042322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the level of patient co-payment for medicines associated with refill adherence in Sweden?
    Lesén E; Andersson Sundell K; Carlsten A; Mårdby AC; Jönsson AK
    Eur J Public Health; 2014 Feb; 24(1):85-90. PubMed ID: 23748594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs.
    Krigsman K; Melander A; Carlsten A; Ekedahl A; Nilsson JL
    Pharm World Sci; 2007 Feb; 29(1):19-24. PubMed ID: 17268941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.
    Hovstadius B; Astrand B; Petersson G
    BMC Clin Pharmacol; 2009 May; 9():11. PubMed ID: 19473486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of introducing propentofylline for the treatment of dementia in Sweden.
    Wimo A; Witthaus E; Rother M; Winblad B
    Clin Ther; 1998; 20(3):552-66; discussion 550-1. PubMed ID: 9663370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary medication non-adherence: analysis of 195,930 electronic prescriptions.
    Fischer MA; Stedman MR; Lii J; Vogeli C; Shrank WH; Brookhart MA; Weissman JS
    J Gen Intern Med; 2010 Apr; 25(4):284-90. PubMed ID: 20131023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug and treatment costs in Parkinson's disease patients in Sweden.
    Lökk J; Borg S; Svensson J; Persson U; Ljunggren G
    Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland.
    Hiligsmann M; McGowan B; Bennett K; Barry M; Reginster JY
    Value Health; 2012; 15(5):604-12. PubMed ID: 22867768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of Leftover Hyperphosphatemia Drugs in Hemodialysis Outpatients].
    Takayama S; Oda M; Saitoh H
    Yakugaku Zasshi; 2021; 141(3):433-440. PubMed ID: 33642513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis.
    Wiréhn AB; Andersson A; Ostgren CJ; Carstensen J
    Diabet Med; 2008 Jun; 25(6):732-7. PubMed ID: 18435778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.
    Carswell C; Wheeler A; Vanderpyl J; Robinson E
    Clin Drug Investig; 2010; 30(11):777-87. PubMed ID: 20712387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary adherence to antidepressant prescriptions in primary health care: a population-based study in Sweden.
    Freccero C; Sundquist K; Sundquist J; Ji J
    Scand J Prim Health Care; 2016; 34(1):83-8. PubMed ID: 26828942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.